Second Qtrol™ Project Commences Clinical Studies

Phoqus EGM approves £3 million Placing to support further clinical development of Chronocort™

Phoqus to raise £3.0 million to support further clinical development of Chronocort™

Interim results for the six months ended 30 June 2006

Appointment of New Non-Executive Director

Phoqus publishes Annual Report and Accounts for 2006

Phoqus announces its inaugural preliminary results for the year ended 31 December 2005.

Phoqus announces that its in-house development programme has successfully completed its Phase I clinical trials programme on Chronocort, the first Circadian endocrine treatment for adrenal insufficiency.

Phoqus announces that it has entered into an agreement to conduct a feasibility study with one of the world's leading medical devices companies.